Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Single Center Trial to Demonstrate the Bioequivalence of a New Combination Analgesic Formulation as Compared to an Equimolar Marketed Formulation

NCT00460785 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT00460785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Single Center Trial to Demonstrate the Bioequivalence of a New Combination Analgesic Formulation as Compared to an Equimolar Marketed Formulation
Lead sponsor
Grünenthal GmbH
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2007
Completion date
March 31, 2007
Enrollment
32
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy